ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,161.50
-1.14%
S&P ASX All Technology
3,742.10
-0.87%
Brent Oil
71.62
-0.29%
US Dollar vs AUD
1.53199
0.76%
Bitcoin
88,080.96
-0.75%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. DNP Select Income Fund Inc (DNP) Share Price

DNP Select Income Fund Inc

DNP Select Income Fund Inc (DNP)

Dai Nippon Printing Co Ltd
9.36
-0.07
(-0.74%)
At close: 13 November 8:00AM
Delayed by 15 minutes
9.36
0.00
( 0.00% )
After Hours: 8:00AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
9.36
Bid
-
Offer
-
Volume
919,559
9.335 Day's Range 9.5198
8.02 52 Week Range 10.04
Market Cap
3.33B
Previous Close
9.43
Open
9.43
Last Trade
617
@
9.36
Last Trade Time
10:30:00
Financial Volume
US$ 8,678,022
VWAP
9.4372
Average Volume (3m)
540,312
Shares Outstanding
355,771,436
Dividend Yield
8.33%
PE Ratio
-17.89
Earnings Per Share (EPS)
-0.52
Revenue
140.97M
Net Profit
-185.92M

About DNP Select Income Fund Inc

The Funds primary investment objectives are current income and longterm growth of income. Capital appreciation is a secondary objective. The Funds primary investment objectives are current income and longterm growth of income. Capital appreciation is a secondary objective.

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Website
www.dpimc.com/dnp
Headquarters
Lutherville Timonium, Maryland, USA
Founded
-
DNP Select Income Fund Inc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the New York Stock Exchange with ticker DNP. The last closing price for DNP Select Income was US$9.43. Over the last year, DNP Select Income shares have traded in a share price range of US$ 8.02 to US$ 10.04.

DNP Select Income currently has 355,771,436 shares in issue. The market capitalisation of DNP Select Income is US$3.35 billion. DNP Select Income has a price to earnings ratio (PE ratio) of -17.89.

Ask ADVFN Intelligence (AI)

DNP Latest News

More News

DNP Select Income Fund Inc. Section 19(a) Notice

Notification of Sources of Distribution Distribution Period October 2024 Distribution Amount Per Share of Common Stock $0.065 The following table sets forth the estimated amounts of the current...

23 hours ago
Business Wire

DNP Select Income Fund Inc. Section 19(a) Notice

Notification of Sources of Distribution Distribution Period September 2024 Distribution Amount Per Share of Common Stock $0.065 The following table sets forth the estimated amounts of the current...

10 October 2024
Business Wire

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

24 September 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

21 September 2024
Edgar (US Regulatory)

DNP Select Income Fund Announces Dividends and Sources of Distribution

The Board of Directors of DNP Select Income Fund Inc. (NYSE: DNP), a closed-end fund advised by Duff & Phelps Investment Management Co., today authorized the payment of dividends on its...

20 September 2024
Business Wire

DNP Select Income Fund Inc. Section 19(a) Notice

Notification of Sources of Distribution Distribution Period August 2024 Distribution Amount Per Share of Common Stock $0.065 The following table sets forth the estimated amounts of the current...

10 September 2024
Business Wire

Form N-PX - Annual Report of proxy voting record of management investment companies

28 August 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

17 August 2024
Edgar (US Regulatory)

DNP Select Income Fund Inc. Section 19(a) Notice

Notification of Sources of Distribution Distribution Period July 2024 Distribution Amount Per Share of Common Stock $0.065 The following table sets forth the estimated amounts of the current...

10 August 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

31 July 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.080.8620689655179.289.539.1356084849.30226007CS
4-0.38-3.901437371669.749.89.14982309.50130167CS
120.232.519167579419.1310.049.15403129.59811912CS
260.353.8845726979.0110.048.026748798.95010281CS
520.374.115684093448.9910.048.027188278.85442943CS
156-1.56-14.285714285710.92128.025885089.98071343CS
260-2.99-24.210526315812.3513.226.7657488710.22645184CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PAYPaymentus Holdings Inc
US$ 33.4399
(25.67%)
100.66k
CAVACAVA Group Inc
US$ 169.50
(16.87%)
1.89M
DNAGinkgo Bioworks Holdings Inc
US$ 9.30
(10.85%)
176.41k
AMPSAltus Power Inc
US$ 3.39
(9.00%)
34.91k
AMBCAmbac Financial Group Inc
US$ 12.60
(7.69%)
10.4k
SAVESpirit Airlines Inc
US$ 1.74
(-45.96%)
8.23M
CHGGChegg Inc
US$ 1.5301
(-13.55%)
1.12M
ALTGAlta Equipment Group Inc
US$ 7.00
(-12.39%)
10.64k
RKTRocket Companies Inc
US$ 13.94
(-10.30%)
780.67k
BWBabcock and Wilcox Enterprises Inc
US$ 2.29
(-9.49%)
81.37k
SAVESpirit Airlines Inc
US$ 1.74
(-45.96%)
8.23M
TAT&T Inc
US$ 22.1515
(0.01%)
4.14M
BTUPeabody Energy Corporation
US$ 28.00
(4.48%)
3M
CAVACAVA Group Inc
US$ 169.50
(16.87%)
1.89M
BPBP Plc
US$ 28.18
(0.07%)
1.88M

Discussion

View Full Feed
The_Gman The_Gman 2 minutes ago
Space. The difference between witnessing a kid napping....and a kidnapping.

Yeah, that's where the pic came from.
NB
ignatiusrielly35 ignatiusrielly35 2 minutes ago
You have no information as to when specifically the ATM is used. Period. In fact, I recall you attributing a price dip earlier this year to dilution in one quarter and the 10q showed virtually none. I repeat, blind guess.
AVXL
12yearplan 12yearplan 3 minutes ago
Sorry for the late reply; .. from your two links and thanks..
 
Summary.
 
Since the early 1970s, hourly inflation-adjusted wages received by the typical worker have barely risen, growing only 0.2% per year. Assigning relative responsibility to the policies and economic f
navycmdr navycmdr 3 minutes ago
https://x.com/InvestIt3/status/1856406733754708460
FNMA
2B_unknown 2B_unknown 3 minutes ago
Yes, we have had the golden ticket for some time now:)

We got this thing, just a matter of time.
NWBO
Hosai Hosai 3 minutes ago
From what I can see based on historical EMA review start dates in late 22 and 23 and aided by chat GPT it guesses the last 2 EMA review start dates for 2024 will be Nov 28th and Dec 27th.
If Anavex were to be aiming for the Nov 28th (ish) it would need to submit any time now. Obv though even
AVXL
MartinLutherKing MartinLutherKing 3 minutes ago
It just hit the wires brother
https://www.forbes.com/sites/jessicaourisman/2024/11/12/the-firsthand-results-of-a-nanofat-treatment-using-stem-cells-and-prp/
ELAB
manibiotech manibiotech 3 minutes ago
Yep nothing for market to be in any FOMO mode 
Likely will slowly go down over next few days without news . As I also said after ASM
ASM
Groveman1 Groveman1 4 minutes ago
Lucky, There's a new response on StockRunners twitter site today 11/12/24 on LLBO. Please check it and see if you can understand what this means for LLBO. StockRunners talks about attorneys and filing papers, but seems to be speaking about the other Company attached to the Post. Check it out.
LLBO
FeMike FeMike 4 minutes ago
I think they would rather say the inspection is completed even if the 10-q is up to September 30 only. If it's done by now since the q was prepared this nov. Therefore, it is not completed up to now.

My personal opinion is that saying "the inspections have been completed" is a bit too
NWBO
cottonisking cottonisking 4 minutes ago
No, peanuts and small money, compared to this board waiting here since 2008 and going through United States' Presidents and nut cases. Shut this mental ward down now. These guys have nothing better to do. Most must be in their 80s.
LEHNQ
northam43 northam43 4 minutes ago
Report #2 October 2024 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2024/11/12/inz[o2_Completed_Cycles.PNG
manibiotech manibiotech 5 minutes ago
Look at section subsequent events in 10 q

Hmm
NWBO
jimr1717 jimr1717 5 minutes ago
New Tesla Involved in a Crash While on FSD, the Teslacam Footage Was All Police Needed
3 Nov 2024, 22:00 UTC •

Bob claims that the moment the pickup truck slammed into his rear end, the FSD turned the steering wheel to the left to prevent his Tesla from hitting the vehicle wait
TSLA
MRJ25 MRJ25 5 minutes ago
Reddit will be better.
FNMA
Rebel13 Rebel13 6 minutes ago
There’s a saying about not being able to find your a$$ even if handed to you. Didn’t realize you were real!
ELTP
art2426 art2426 6 minutes ago
We're not getting into politics? Really? Who exactly brought THIS up? ---- "Especially with the new pro small business President we just elected!"


How is reading this board, NOT FUN?
BIEL
jimr1717 jimr1717 6 minutes ago
How? Watch and learn.
TSLA
mrwrn2010 mrwrn2010 7 minutes ago
Blast from the past!
ELTP
Mactheriverrat Mactheriverrat 7 minutes ago
Thoughts on TLRY?
TLRY
exwannabe exwannabe 7 minutes ago
Reimbursement. The Company has evaluated and selected specialized, highly experienced consultants with whom to undertake preparations for a potential reimbursement review ...
In other words, not even close to submitting the evidence that kicks off the NICE process.
NWBO
gdog gdog 8 minutes ago
11-12 buy/cover EVH $14.19 + 4.15%
MahinAgency MahinAgency 8 minutes ago
H.C. Wainwright maintains a "Buy" rating for Cardiol Therapeutics with a price target of $9.00.

MAVERIC-2 trial aims to assess CardiolRx in recurrent pericarditis patients post-IL-1 blocker therapy.
CRDL
againstallodds againstallodds 8 minutes ago
Market expects gold delivery, imagine if no delivery

No gold = no created value
NBRI
CommodityCoverage CommodityCoverage 8 minutes ago
Developing therapeutic compounds for pediatric diseases with unmet medical needs and a large addressable market, clinical-stage biotech company Thiogenesis Therapeutics (TTI.v), recently announced the approval of its European patent for the treatment of Cysteamine Sensitive Disorders, a medical cond
TTI

Your Recent History

NYSE
DNP
DNP Select Income
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved